ATE504596T1 - Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus - Google Patents

Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Info

Publication number
ATE504596T1
ATE504596T1 AT06735670T AT06735670T ATE504596T1 AT E504596 T1 ATE504596 T1 AT E504596T1 AT 06735670 T AT06735670 T AT 06735670T AT 06735670 T AT06735670 T AT 06735670T AT E504596 T1 ATE504596 T1 AT E504596T1
Authority
AT
Austria
Prior art keywords
immune deficiency
deficiency virus
polypeptides
fiv
detecting cat
Prior art date
Application number
AT06735670T
Other languages
English (en)
Inventor
Randall Groat
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE504596T1 publication Critical patent/ATE504596T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06735670T 2005-03-09 2006-02-22 Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus ATE504596T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/075,480 US7291338B2 (en) 2005-03-09 2005-03-09 Method and device for detecting feline immunodeficiency virus
PCT/US2006/006107 WO2006098849A2 (en) 2005-03-09 2006-02-22 Method and device for detecting feline immunodeficiency virus

Publications (1)

Publication Number Publication Date
ATE504596T1 true ATE504596T1 (de) 2011-04-15

Family

ID=36971944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06735670T ATE504596T1 (de) 2005-03-09 2006-02-22 Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Country Status (9)

Country Link
US (1) US7291338B2 (de)
EP (1) EP1866330B1 (de)
JP (1) JP2008533006A (de)
AT (1) ATE504596T1 (de)
AU (1) AU2006223631B2 (de)
CA (1) CA2598230A1 (de)
DE (1) DE602006021162D1 (de)
ES (1) ES2363537T3 (de)
WO (1) WO2006098849A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010508520A (ja) * 2006-10-31 2010-03-18 エス アール ユー バイオシステムズ，インコーポレイテッド 官能基が付与された表面上の非特異的タンパク質結合をブロッキングする方法
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
KR101219505B1 (ko) 2010-05-28 2013-01-31 베트올 (주) 고양이 톡소포자충 감염 진단 방법 및 키트
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
JP6370792B2 (ja) * 2012-10-03 2018-08-08 ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト タンパク質の精製方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4879212A (en) 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US4900548A (en) 1987-11-13 1990-02-13 Harvard University Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
CA1335880C (en) 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
JP3058685B2 (ja) 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
FR2669338A1 (fr) 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
ATE160358T1 (de) 1991-06-14 1997-12-15 St Vincents Inst Med Res Detektion des immunschwäche-virus aus felis
WO1993001304A1 (en) 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5736378A (en) 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
US5462852A (en) 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
DE4242475A1 (de) 1992-12-16 1994-06-23 Suspa Compart Ag Führungsbuchse, insbesondere für längenverstellbare Stuhl-Säule und Stuhl-Säule mit derartiger Führungsbuchse
US5576177A (en) 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
AU2234995A (en) 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
FR2721031B1 (fr) 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.
DE59511054D1 (de) 1994-07-25 2006-08-10 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
FR2732346B1 (fr) 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
DE69636440D1 (de) 1995-08-25 2006-09-21 Univ Florida IL-2 unabhängige T-Zellen der Katze
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6077662A (en) 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6331616B1 (en) 1997-03-05 2001-12-18 North Carolina State University Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3
FR2769916B1 (fr) 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
JP2001525347A (ja) 1997-12-05 2001-12-11 ザ ユニバーシティ オブ ニュー メキシコ 熱ショックペプチド錯体の精製方法
US6284253B1 (en) 1998-01-29 2001-09-04 Cornell Research Foundation, Inc. Feline immunodeficiency virus (FIV) nucleotide sequence
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
WO2001004280A2 (de) 1999-07-08 2001-01-18 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
DE60042338D1 (de) 1999-10-04 2009-07-16 Univ New Jersey Med TAR RNA bindende Peptide
FR2828687B1 (fr) 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
MXPA05012270A (es) 2003-05-12 2006-02-10 Univ Florida Materiales y metodos para inmunizar en contra de la infeccion por virus de inmunodeficiencia de felino.
ATE435425T1 (de) * 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus

Also Published As

Publication number Publication date
EP1866330B1 (de) 2011-04-06
CA2598230A1 (en) 2006-09-21
JP2008533006A (ja) 2008-08-21
EP1866330A2 (de) 2007-12-19
AU2006223631A1 (en) 2006-09-21
WO2006098849A2 (en) 2006-09-21
ES2363537T3 (es) 2011-08-08
US20060205923A1 (en) 2006-09-14
AU2006223631B2 (en) 2009-12-17
US7291338B2 (en) 2007-11-06
WO2006098849A3 (en) 2007-04-19
DE602006021162D1 (de) 2011-05-19

Similar Documents

Publication Publication Date Title
DE60326336D1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
WO2008147382A8 (en) Integrated microfluidic assay devices and methods
EA200971124A1 (ru) Множественный анализ образцов крови
EA201171046A1 (ru) Зонды и праймеры для детектирования вируса чикунгуньи
DE602004003842D1 (de) Verfahren und automatisiertes Microfluidsystem zum Nachweis von Proteinen in biologischen Proben
ATE466108T1 (de) Optoelektronisches detektionssystem
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
DE50109723D1 (de) Nachweis und identifikation von bakteriengruppen
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
ATE443154T1 (de) Vorrichtung und verfahren zur bestimmung und klassifizierung von chemikalien, partikeln, viren und bakterien in fluiden mittels aptamer
ATE504596T1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
BRPI0519354B8 (pt) método para detecção de um anticorpo terapêutico e uso de um anticorpo
ATE518594T1 (de) Geräte und verfahren zur positionierung von robenverarbeitungsvorrichtungen
ATE537191T1 (de) Protein, verfahren zur proteinimmobilisierung, struktur, biosensor, nukleinsäure, vektor und kit für den nachweis einer zielsubstanz
DE60307337D1 (de) Verfahren zur Identifizierung von Umweltkontaminationen durch Detektion von Enteroviren
MX2010005713A (es) Metodo y kit para detectar virus de diarrea viral bovina en muestras tisulares.
ATE504834T1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
DE602004021724D1 (de) Verfahren zum nachweis des felinen immunschwächevirus
DE602004005026D1 (de) RT-PCR-Verfahren zum quantitativen Nachweis von HDV
WO2006062427A8 (en) Method for quantitatively detecting biological toxins
ATE485060T1 (de) Verfahren zur diagnose von infektionskrankheiten
ATE522833T1 (de) Vorrichtung zur detektion von chemischen oder biologischen substanzen und verfahren zum reinigen der vorrichtung
ATE520985T1 (de) Verfahren zur bestimmung von antigen und antikörper gegen das antigen
DE602004006434D1 (de) Proteomwechselwirkungskartierung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties